Deroy & Devereaux Private Investment Counsel Inc Amgen Inc Transaction History

Deroy & Devereaux Private Investment Counsel Inc

$1.75 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $205,722 - $252,449	-1,040 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $8,705 - $10,431	-50 Reduced 4.59%	1,040 $201,000
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 4.39%	1,090 $207,000
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 4.2%	1,140 $236,000
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $11,789 - $13,242	-71 Reduced 5.63%	1,190 $220,000
Q1 2018 Apr 27, 2018	BUY	$169.43 - $198.0 $213,651 - $249,678	1,261 New	1,261 $215,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deroy & Devereaux Private Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deroy & Devereaux Private Investment Counsel Inc with notifications on news.

Account